BIOXYNE LIMITED — Capital/Financing Update 2017

Apr 18, 2017

==> picture [596 x 109] intentionally omitted <==

----- Start of picture text ----- Suite 506, Level 5, 50 Clarence StSydney NSW 2000P: +61 2 9078 8180W: www.bioxyne.com----- End of picture text -----

19 April 2017

Company Announcements

ASX Limited

Information Disclosed Under ASX LR 3.10.5A and 7.1A.4(b)

Further to the ASX announcement of 19 April 2017 and Appendix 3B lodged by Bioxyne Limited (Bioxyne or the Company) today regarding the issue of shares to the vendors of the business and the issue of the sign on fee shares, Bioxyne provides the following additional information under ASX Listing Rule 3.10.5A:

• (a) The Company issued 22,500,000 shares of which 20,242,610 shares were issued under Listing Rule 7.1A and the remaining shares (2,257,390) were issued under the Company’s 15% placement capacity under Listing Rule 7.1.

The securities issued under Listing Rule 7.1A resulted in the following dilution to existing holders of ordinary securities.

• Number of fully paid ordinary shares on issue prior to this issue of securities under LR7.1A was 204,683,491.

• Number of fully paid ordinary shares on issue following this issue of securities under LR7.1A was 224,926,101.

• Percentage of voting dilution following this issue is 9%.

• (b) Bioxyne issued the shares as a placement under Listing Rule 7.1A as operationally it was important to conclude this transaction at this time, and the deemed price at which the shares have been issue is only a 5% discount to the 15 day VWAP prior to the date of issue. Bioxyne will use its remaining LR 7.1 capacity for the placement as outlined in the ASX announcement of 19 April 2017.

• (c) The placement was not underwritten.

• (d) No broker fees are payable in connection with the issue.

Guy Robertson

Company Secretary